Skip to main content


Page 2 of 70

  1. Significant bleeding of tumor sites is a dreaded complication in oncological diseases and often results in clinical emergencies. Besides basic local and interventional procedures, an urgent radiotherapeutic ap...

    Authors: Manuel Guhlich, Teresa Esther Maag, Leif Hendrik Dröge, Andrea Hille, Sandra Donath, Stephanie Bendrich, Markus Anton Schirmer, Friedemann Nauck, Martin Leu, Joachim Riggert, Julia Gallwas and Stefan Rieken
    Citation: Radiation Oncology 2023 18:203
  2. Single-fraction stereotactic radiosurgery (SRS) is an established standard for radiation therapy of brain metastases although recent developments indicate that multi-fractionated stereotactic radiotherapy (FSR...

    Authors: Isabella Gruber, Karin Weidner, Marius Treutwein and Oliver Koelbl
    Citation: Radiation Oncology 2023 18:202
  3. This study aimed to compare the outcomes of patients with ground-grass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) who were treated with carbon ion radiotherapy (CIRT) versus segmentectomy.

    Authors: Teruaki Mizobuchi, Akihiro Nomoto, Hironobu Wada, Naoyoshi Yamamoto, Mio Nakajima, Takehiko Fujisawa, Hidemi Suzuki and Ichiro Yoshino
    Citation: Radiation Oncology 2023 18:201
  4. Breast cancer is the most widespread cancer in women and young women worldwide. Moving towards customised radiotherapy, balancing the use of the available technology with the best treatment modality may not be...

    Authors: Ke Yuan, Xinghong Yao, Xiongfei Liao, Pen Diao, Xin Xin, Jiabao Ma, Jie Li and Lucia Clara Orlandini
    Citation: Radiation Oncology 2023 18:200
  5. Authors: Taro Shibuki, Mitsuhito Sasaki, Shota Yamaguchi, Kanae Inoue, Tomonao Taira, Tomoyuki Satake, Kazuo Watanabe, Hiroshi Imaoka, Shuichi Mitsunaga, Takeshi Fujisawa, Kento Tomizawa, Hidekazu Oyoshi, Masaki Nakamura, Hidehiro Hojo and Masafumi Ikeda
    Citation: Radiation Oncology 2023 18:199

    The original article was published in Radiation Oncology 2023 18:178

  6. Radiation-induced damage (RID) after radiotherapy (RT) of primary brain tumors and metastases can be challenging to clinico-radiographically distinguish from tumor progression. RID includes pseudoprogression a...

    Authors: Mario R. P. Kossmann, Felix Ehret, Siyer Roohani, Sebastian F. Winter, Pirus Ghadjar, Güliz Acker, Carolin Senger, Simone Schmid, Daniel Zips and David Kaul
    Citation: Radiation Oncology 2023 18:198
  7. So far, only limited studies exist that evaluate patients with brain metastases (BM) from GI cancer and associated primary cancers who were treated by Gamma Knife Radiosurgery (GKRS) and concomitant immunother...

    Authors: Farjad Khalaveh, Anna Cho, Abdallah Shaltout, Helena Untersteiner, Beate Kranawetter, Dorian Hirschmann, Philipp Göbl, Wolfgang Marik, Brigitte Gatterbauer, Karl Rössler, Christian Dorfer and Josa M. Frischer
    Citation: Radiation Oncology 2023 18:197
  8. The study retrospectively analyzed the accuracy and predictive ability of preoperative integrated whole-body 18F-FDG PET/CT for the assessment of high-risk factors in patients with endometrial carcinoma (EC).

    Authors: Ye Yang, Yu-Qin Pan, Min Wang, Song Gu and Wei Bao
    Citation: Radiation Oncology 2023 18:196
  9. Concurrent chemoradiotherapy has been standard of care for unresectable esophageal carcinoma. There were no reports on proton radiotherapy (PRT) plus carbon-ion radiotherapy (CIRT) with pencil beam scanning (P...

    Authors: Ningyi Ma, Xue Ming, Jian Chen, Kai-Liang Wu, Jiade Lu, Guoliang Jiang and Jingfang Mao
    Citation: Radiation Oncology 2023 18:195
  10. To report the planning benchmark case results of the POTENTIAL trial—a multicenter, randomized, phase 3 trial—to evaluate the value of internal mammary nodal (IMN) irradiation for patients with high-risk breas...

    Authors: Yu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, Hui Fang, Yu Tang, Hao Jing, Kuo Men, Na Zhang, Jun Zhang, Jing Jin, Qiu-Zi Zhong, Jun Ma, Wei-Fang Yang, Ya-Hua Zhong, Li-Hua Dong, Xiao-Hong Wang…
    Citation: Radiation Oncology 2023 18:194
  11. FLT-PET/CT can accurately identify and locate functional bone marrow (FBM) with hematopoietic capability, the FBM were divided into two levels as FBM1 (strongest hemopoietic ability region)and FBM2 (moderate hemo...

    Authors: Hongbo Chen, Qian Zhong, Yujie Liu, Jinyan Li, Wenjing Deng, Jie Wang, Shuquan Zhou, Zengrong Yu, Xianzhan Huang, Yuanqiong Huang, Bo Zhen, Jihong Wei, Weijian Zhang, Xiaohong Ruan and Lin Xiao
    Citation: Radiation Oncology 2023 18:193
  12. Highly modulated radiotherapy plans aim to achieve target conformality and spare organs at risk, but the high complexity of the plan may increase the uncertainty of treatment. Thus, patient-specific quality as...

    Authors: Liyuan Chen, Huanli Luo, Shi Li, Xia Tan, Bin Feng, Xin Yang, Ying Wang and Fu Jin
    Citation: Radiation Oncology 2023 18:192
  13. Previous researches have demonstrated that adaptive replanning during intensity-modulated radiation therapy (IMRT) could enhance the prognosis of patients with nasopharyngeal carcinoma (NPC). However, the deli...

    Authors: Xiate Zhou, Jian Zhu, Chao Zhou, Wei Wang, Weijun Ding, Meng Chen, Kuifei Chen, Shuling Li, Xiaofeng Chen and Haihua Yang
    Citation: Radiation Oncology 2023 18:190
  14. To discuss the optimal treatment modality for inoperable locally advanced Non-Small Cell Lung Cancer patients with poor physical status, impaired cardio-pulmonary function, and negative driver genes, and provi...

    Authors: Yonglong Jin, Shosei Shimizu, Yinuo Li, Yuan Yao, Xiguang Liu, Hongzong Si, Hideyuki Sakurai and Wenjing Xiao
    Citation: Radiation Oncology 2023 18:189
  15. In a recent phase III randomized control trial, delivering a focal radiotherapy (RT) boost to tumors visible on MRI was shown to improve disease-free survival and regional/distant metastasis-free survival for ...

    Authors: Allison Y. Zhong, Asona J. Lui, Matthew S. Katz, Alejandro Berlin, Sophia C. Kamran, Amar U. Kishan, Vedang Murthy, Himanshu Nagar, Daniel Seible, Bradley J. Stish, Alison C. Tree and Tyler M. Seibert
    Citation: Radiation Oncology 2023 18:188
  16. Few dosimetric comparisons have been published between linear accelerator (LA)-based systems and CyberKnife (CK)-based robotic radiosurgery systems for cardiac radio-ablation in ventricular tachycardia. This s...

    Authors: Ching-Yu Wang, Li-Ting Ho, Lian-Yu Lin, Hsing-Min Chan, Hung-Yi Chen, Tung-Lin Yu, Yu-Sen Huang, Sung-Hsin Kuo, Wen-Jeng Lee and Jenny Ling-Yu Chen
    Citation: Radiation Oncology 2023 18:187
  17. Intraoperative radiation therapy (IORT) is a radiation technique applying a single fraction with a high dose during surgery. We report the first abdomino-pelvic application of an image-guided intraoperative el...

    Authors: Falk Roeder, Gerd Fastner, Christoph Fussl, Felix Sedlmayer, Markus Stana, Johannes Berchtold, Tarkan Jäger, Jaroslav Presl, Philipp Schredl, Klaus Emmanuel, Daniela Colleselli, Gabriel Kotolacsi, Philipp Scherer, Philipp Steininger and Christoph Gaisberger
    Citation: Radiation Oncology 2023 18:186
  18. Stereotactic arrhythmia radioablation (STAR) is delivered with a planning target volume (PTV) prescription dose of 25 Gy, mostly to the surrounding 75–85% isodose line. This means that the average and maximum ...

    Authors: Boldizsar Kovacs, Michael Mayinger, Stefanie Ehrbar, Debra Fesslmeier, Maiwand Ahmadsei, Lorraine Sazgary, Robert Manka, Hatem Alkadhi, Frank Ruschitzka, Firat Duru, Alexandros Papachristofilou, Christian Sticherling, Slawomir Blamek, Krzysztof S. Gołba, Matthias Guckenberger, Ardan M. Saguner…
    Citation: Radiation Oncology 2023 18:185
  19. Radiotherapy is widely used in treating cervical cancer patients, however, radioresistance unavoidably occurs and seriously affects the treatment effect. It is well known that hypoxia plays an important role i...

    Authors: Junying Zhou, Ningjing Lei, Wanjia Tian, Ruixia Guo, Feng Gao, Hanlin Fu, Jing Zhang, Shiliang Dong, Mengyu Chen, Qian Ma, Yong Li and Lei Chang
    Citation: Radiation Oncology 2023 18:183
  20. Although magnetic resonance imaging (MRI)-to-computed tomography (CT) synthesis studies based on deep learning have significantly progressed, the similarity between synthetic CT (sCT) and real CT (rCT) has onl...

    Authors: Siqi Yuan, Xinyuan Chen, Yuxiang Liu, Ji Zhu, Kuo Men and Jianrong Dai
    Citation: Radiation Oncology 2023 18:182
  21. Adjuvant whole breast radiotherapy and systemic therapy are part of the current evidence-based treatment protocols for early breast cancer, after breast-conserving surgery. Numerous randomized trials have inve...

    Authors: Jan Haussmann, Wilfried Budach, Stefanie Corradini, David Krug, Danny Jazmati, Bálint Tamaskovics, Edwin Bölke, Alessia Pedotoa, Kai Kammers and Christiane Matuschek
    Citation: Radiation Oncology 2023 18:181
  22. Intensity-modulated radiation therapy (IMRT) requires delivery quality assurance (DQA) to ensure treatment accuracy and safety. Irradiation techniques such as helical tomotherapy (HT) have become increasingly ...

    Authors: Yuichi Tanaka, Masatoshi Hashimoto, Minoru Ishigami, Masahiro Nakano and Tomoyuki Hasegawa
    Citation: Radiation Oncology 2023 18:180
  23. To develop and validate radiomics models for prediction of tumor response to neoadjuvant therapy (NAT) in patients with locally advanced rectal cancer (LARC) using both pre-NAT and post-NAT multiparameter magn...

    Authors: Hongyan Huang, Lujun Han, Jianbo Guo, Yanyu Zhang, Shiwei Lin, Shengli Chen, Xiaoshan Lin, Caixue Cheng, Zheng Guo and Yingwei Qiu
    Citation: Radiation Oncology 2023 18:179
  24. Patients with unresectable pancreatic cancer (PC) sometimes experience gastrointestinal bleeding (GIB) due to tumor invasion of the gastrointestinal tract (tumor bleeding); no standard treatment has been estab...

    Authors: Taro Shibuki, Mitsuhito Sasaki, Shota Yamaguchi, Kanae Inoue, Tomonao Taira, Tomoyuki Satake, Kazuo Watanabe, Hiroshi Imaoka, Shuichi Mitsunaga, Takeshi Fujisawa, Kento Tomizawa, Hidekazu Oyoshi, Masaki Nakamura, Hidehiro Hojo and Masafumi Ikeda
    Citation: Radiation Oncology 2023 18:178

    The Correction to this article has been published in Radiation Oncology 2023 18:199

  25. This study aimed to evaluate an a-priori multicriteria plan optimization algorithm (mCycle) for locally advanced breast cancer radiation therapy (RT) by comparing automatically generated VMAT (Volumetric Modul...

    Authors: Livia Marrazzo, Laura Redapi, Roberto Pellegrini, Peter Voet, Icro Meattini, Chiara Arilli, Silvia Calusi, Marta Casati, Deborah Chilà, Antonella Compagnucci, Cinzia Talamonti, Margherita Zani, Lorenzo Livi and Stefania Pallotta
    Citation: Radiation Oncology 2023 18:176
  26. Accurate prediction of response to neoadjuvant chemoradiotherapy (nCRT) is very important for treatment plan decision in locally advanced rectal cancer (LARC). The aim of this study was to investigate whether ...

    Authors: Xuezhi Zhou, Yi Yu, Yanru Feng, Guojun Ding, Peng Liu, Luying Liu, Wenjie Ren, Yuan Zhu and Wuteng Cao
    Citation: Radiation Oncology 2023 18:175
  27. Randomized controlled study was conducted to evaluate the efficacy of Sanyrene® vs. control intervention (DaBao®, a complex of hyaluronic acid and Vitamin E) for acute radiation dermatitis in patients receivin...

    Authors: Xiaoli Long, Jing Guo, Yutian Yin, Ming Cheng, Xiao Zhang, Jing Zhang, Pengyuan Wang, Jian Zang and Lina Zhao
    Citation: Radiation Oncology 2023 18:174
  28. Spacer placement surgery is useful in particle therapy (PT) for patients with abdominopelvic malignant tumors located adjacent to the gastrointestinal tract. This study aimed to assess the safety, efficacy, an...

    Authors: Ryosuke Fujinaka, Shohei Komatsu, Kazuki Terashima, Yusuke Demizu, Satoshi Omiya, Masahiro Kido, Hirochika Toyama, Sunao Tokumaru, Tomoaki Okimoto and Takumi Fukumoto
    Citation: Radiation Oncology 2023 18:173
  29. Limited studies explored the relationship between lymphocyte recovery after definitive concurrent chemoradiotherapy (dCCRT) and prognosis in esophageal squamous cell carcinoma (ESCC).

    Authors: Ihsuan Tseng, Dashan Ai, Yun Chen, Hongcheng Zhu, Fangfang Li, Yang Xu, Lu Yu, Qi Liu, Jiaying Deng, Shengnan Hao, Zhengfei Zhu, Weixin Zhao, Min Fan, Ling Li, Fengtao Su and Kuaile Zhao
    Citation: Radiation Oncology 2023 18:172
  30. Fatigue during radiation therapy in women with breast cancer can decrease quality of life (QOL), yet it is often underestimated and needs to be evaluated objectively. This longitudinal study aimed to evaluate ...

    Authors: Miwa Aoki, Hirohiko Kuratsune, Sena Yamamoto, Toshiko Hirano, Kumiko Hanaeda, Yasuka Nishi, Tamami Okada, Maki Nadamura, Chiho Kobayashi, Emiko Sumita, Junko Gotou, Masahiko Koizumi and Harue Arao
    Citation: Radiation Oncology 2023 18:171
  31. Accurate delineation of clinical target volume of tumor bed (CTV-TB) is important but it is also challenging due to surgical effects and soft tissue contrast. Recently a few auto-segmentation methods were deve...

    Authors: Xin Xie, Yuchun Song, Feng Ye, Shulian Wang, Hui Yan, Xinming Zhao and Jianrong Dai
    Citation: Radiation Oncology 2023 18:170
  32. Patients with locoregionally uncontrolled breast tumors are frequently referred for breast palliative radiotherapy (PRT) to mitigate symptoms. We analyzed the outcomes following breast PRT to optimize PRT acco...

    Authors: Nalee Kim, Haeyoung Kim, Won Park, Won Kyung Cho, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park and Ji-Yeon Kim
    Citation: Radiation Oncology 2023 18:168
  33. The integration of Artificial Intelligence (AI) technology in cancer care has gained unprecedented global attention over the past few decades. This has impacted the way that cancer care is practiced and delive...

    Authors: Iman Hesso, Reem Kayyali, Debbie-Rose Dolton, Kwanyoung Joo, Lithin Zacharias, Andreas Charalambous, Maria Lavdaniti, Evangelia Stalika, Tarek Ajami, Wanda Acampa, Jasmina Boban and Shereen Nabhani-Gebara
    Citation: Radiation Oncology 2023 18:167
  34. Head and neck cancer is a kind of cancer which can be eradicated from radical radiation therapy. However, with best efforts, nearly 40% patients will experience locoregional recurrence. Locoregional recurrence...

    Authors: Shu Zhang, Ni Zeng, Jiangping Yang, Jinlan He, Fubin Zhu, Wenjun Liao, Maoqi Xiong and Yan Li
    Citation: Radiation Oncology 2023 18:166
  35. The aim was to assess the feasibility of online adaptive radiotherapy (oART) for bladder cancer using a focal boost by focusing on the quality of the online treatment plan and automatic target delineation, dur...

    Authors: Sana Azzarouali, Karin Goudschaal, Jorrit Visser, Maarten Hulshof, Marjan Admiraal, Niek van Wieringen, Jakko Nieuwenhuijzen, Jan Wiersma, Laurien Daniëls, Duncan den Boer and Arjan Bel
    Citation: Radiation Oncology 2023 18:165
  36. Manual clinical target volume (CTV) and gross tumor volume (GTV) delineation for rectal cancer neoadjuvant radiotherapy is pivotal but labor-intensive. This study aims to propose a deep learning (DL)-based wor...

    Authors: Jianhao Geng, Xianggao Zhu, Zhiyan Liu, Qi Chen, Lu Bai, Shaobin Wang, Yongheng Li, Hao Wu, Haizhen Yue and Yi Du
    Citation: Radiation Oncology 2023 18:164
  37. The THUNDER-2 phase II single institutional trial investigates the benefits of MRI-guided radiotherapy (MRIgRT) in treating locally advanced rectal cancer (LARC). This study focuses on evaluating the impact of...

    Authors: Giuditta Chiloiro, Angela Romano, Davide Cusumano, Luca Boldrini, Giulia Panza, Lorenzo Placidi, Elisa Meldolesi, Matteo Nardini, Guenda Meffe, Gianluca Nicolini, Claudio Votta, Luca Indovina and Maria Antonietta Gambacorta
    Citation: Radiation Oncology 2023 18:163
  38. To compare intensity reduction plans for liver cancer with or without a magnetic field and optimize field and subfield numbers in the intensity-modulated radiotherapy (IMRT) plans designed for liver masses in ...

    Authors: Xin Liu, Peijun Yin, Tengxiang Li, Yong Yin and Zhenjiang Li
    Citation: Radiation Oncology 2023 18:162
  39. One of the main limiting factors of whole-brain radiation therapy (WBRT) for primary central nervous system lymphoma (PCNSL) is the impairment of neurocognitive functions (NCFs), which is mainly caused by radi...

    Authors: Ciro Mazzarella, Silvia Chiesa, Lucrezia Toppi, Stefan Hohaus, Simona Gaudino, Francesco D’Alo, Nicola Dinapoli, Resta Davide, Tiziano Zinicola, Serena Bracci, Antonella Martino, Francesco Beghella Bartoli, Elisabetta Lepre, Roberta Bertolini, Silvia Mariani, Cesare Colosimo…
    Citation: Radiation Oncology 2023 18:161
  40. In pediatric radiotherapy treatment planning of abdominal tumors, dose constraints to the pancreatic tail/spleen are applied to reduce late toxicity. In this study, an analysis of inter- and intrafraction moti...

    Authors: Fasco Van Ommen, Gaelle A.T. le Quellenec, Mirjam E. Willemsen-Bosman, Max M. van Noesel, Marry M. van den Heuvel-Eibrink, Enrica Seravalli, Petra S. Kroon and Geert O. Janssens
    Citation: Radiation Oncology 2023 18:160
  41. The present study identified survival and progression-free rates and evaluated prognostic factors for IVB stage cervical cancer in patients that presented with synchronous oligometastases (sync-oligometastases...

    Authors: Junyun Li, Ying Wang, Lanqing Huo, Xiaodan Huang, Liu Shi, Lin Huang, Kai Chen and Xinping Cao
    Citation: Radiation Oncology 2023 18:159
  42. The goal of this study was to obtain maximum allowed shift deviations from planning position in six degrees of freedom (DOF), that can serve as threshold values in surface guided radiation therapy (SGRT) of br...

    Authors: Tim-Oliver Sauer, Wilhelm Stillkrieg, Oliver J. Ott, Rainer Fietkau and Christoph Bert
    Citation: Radiation Oncology 2023 18:158
  43. Setup reproducibility of the tissue in the proton beam path is critical in maintaining the planned clinical target volume (CTV) dose coverage and sparing the organs at risk (OAR). In this study, we retrospecti...

    Authors: Yixiu Kang, Martin Bues, Michele Y. Halyard, Lisa A. McGee, Tamara Z. Vern-Gross, William W. Wong, Sameer R. Keole, Carlos Vargas, Sarah E. James, Safia K. Ahmed, James P. Archuleta, Ana K. Ridgway, Pedro R. Lara and Mirek Fatyga
    Citation: Radiation Oncology 2023 18:157
  44. This study evaluated the treatment outcomes of spine stereotactic body radiation therapy (SBRT) in sarcoma patients.

    Authors: Eunji Kim, Mi-Sook Kim, Eun Kyung Paik, Ung-Kyu Chang and Chang-Bae Kong
    Citation: Radiation Oncology 2023 18:156

    The Correction to this article has been published in Radiation Oncology 2023 18:184

  45. To investigate the frequency of temporal lobe necrosis (TLN) soon after radiotherapy (RT) and identify differences among patients with various types of head and neck cancer (HNC) and between different RT methods.

    Authors: Chi-Hung Liu, Chien-Yu Lin, Bing-Shen Huang, Yi-Chia Wei, Ting-Yu Chang, Chih-Hua Yeh, Pi-Shan Sung, Jian-Lin Jiang, Li-Ying Lin, Joseph Tung-Chieh Chang and Kang-Hsing Fan
    Citation: Radiation Oncology 2023 18:155
  46. Definitive radiotherapy (RT) is an alternative to radical cystectomy for select patients with muscle invasive bladder cancer (MIBC); however, there is limited data on dose-painted RT approaches. We report the ...

    Authors: Inmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, Michael Tjong, Vickie Kong, Victor Malkov, Tony Tadic, Neil Fleshner, Girish Kulkarni, Alexandre R Zlotta, Charles Catton, Alejandro Berlin, Srikala Sridhar, Di (Maria) Jiang, Peter Chung and Srinivas Raman
    Citation: Radiation Oncology 2023 18:154

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    605 Altmetric mentions